EUVIMEDOpdag EUVIMED
Crossref

Assessment of right ventricular functions during cancer chemotherapy

Asli Tanindi, Umut Demirci, Gulten Tacoy, Suleyman Buyukberber, Yakup Alsancak, Ugur Coskun, Ridvan Yalcin, Mustafa Benekli

European Journal of Echocardiography · 2011-11-01 · 12 (11) · 834-840

DOI: 10.1093/ejechocard/jer142 ↗

At a glance

Journal article in European Journal of Echocardiography, published online on 2011-08-30. Written by Asli Tanindi and 7 co-authors. Institution: Department of Cardiology, Gazi University Faculty of Medicine, Besevler, Ankara, Turkey. aslitanindi@gmail.com. Cited 63 times so far (Crossref); 42 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

AIMS: Although systolic and diastolic left ventricular functions after cancer chemotherapy are well studied, there are a few investigations about the right ventricular functions. We aimed to investigate the early effects of chemotherapy on right heart, if any, in addition to the association between N-terminal pro-brain natriuretic peptide (NT-proBNP) and right heart echocardiographic indices. METHODS AND RESULTS: Thirty-seven consecutive patients with newly diagnosed breast cancer who were planned to receive either AC protocol [cyclophosphamide (600 mg/m(2)) + adriamycin (60 mg/m(2))] or CAF protocol [cyclophosphamide (600 mg/m(2)) + adriamycin (60 mg/m(2)) + 5-fluorouracil (600 mg/m(2))] for six cures were enrolled between February 2009 and June 2010. Echocardiography was performed before the onset of the chemotheurapeutic regimen (T1), on the day after the completion of the first cure (T2), and after the completion of two cures of the regimen (T3). Serum NT-proBNP levels were also measured at T1, T2, and T3. The mean right ventricular fractional area change (RVFAC) was 63.7 ± 3.63, 63.3 ± 3.67, and 61.2 ± 4.41% at T1, T2, and T3, respectively (pT1-T3 and pT2-T3

Subjects

MeSH terms (MEDLINE)

AdultAntineoplastic Combined Chemotherapy ProtocolsBreast NeoplasmsCyclophosphamideDoxorubicinEchocardiography, DopplerFemaleFluorouracilHumansMaleMiddle AgedNatriuretic Peptide, BrainVentricular Dysfunction, Right

Substances

Natriuretic Peptide, BrainDoxorubicinCyclophosphamideFluorouracil

Authors and institutions

  • Department of Cardiology, Gazi University Faculty of Medicine, Besevler, Ankara, Turkey. aslitanindi@gmail.com

Cite

APA

Tanindi, A., Demirci, U., Tacoy, G., Buyukberber, S., Alsancak, Y., Coskun, U., Yalcin, R., & Benekli, M. (2011). Assessment of right ventricular functions during cancer chemotherapy. European Journal of Echocardiography, 12(11), 834-840. https://doi.org/10.1093/ejechocard/jer142

Vancouver

Tanindi A, Demirci U, Tacoy G, Buyukberber S, Alsancak Y, Coskun U, et al. Assessment of right ventricular functions during cancer chemotherapy. European Journal of Echocardiography. 2011;12(11):834-840. doi:10.1093/ejechocard/jer142

BibTeX
@article{Tanindi2011,
  author = {Tanindi, Asli and Demirci, Umut and Tacoy, Gulten and Buyukberber, Suleyman and Alsancak, Yakup and Coskun, Ugur and Yalcin, Ridvan and Benekli, Mustafa},
  title = {Assessment of right ventricular functions during cancer chemotherapy},
  journal = {European Journal of Echocardiography},
  year = {2011},
  volume = {12},
  number = {11},
  pages = {834--840},
  doi = {10.1093/ejechocard/jer142}
}
Start for free →